Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P53 regulation and function in normal cells and tumors.

Y Liu1, M Kulesz-Martin

  • 1Department of Dermatology and Oregon Cancer Center, Oregon Health Sciences University, Portland, OR, USA.

Medicina
|February 24, 2001
PubMed
Summary

The tumor suppressor p53 protein

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.

Science advances·2019
Same author

Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling.

Oncogene·2016
Same author

p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.

Oncogene·2007
Same author

p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding.

Carcinogenesis·2001
Same author

Identification of a novel structural variant of the alpha 6 integrin.

The Journal of biological chemistry·2001
Same author

Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.

Nucleic acids research·2001

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The p53 pathway is crucial for protecting cells from DNA damage.
  • p53 protein exhibits both specific and non-specific DNA binding capabilities.
  • Understanding p53's in-cell behavior after DNA damage is critical.

Purpose of the Study:

  • To investigate the DNA binding activity of p53 proteins in cells responding to DNA damage.
  • To compare p53 binding in normal keratinocytes versus squamous cell carcinoma (SCC) cells.
  • To explore the link between p53 DNA binding and cellular responses like apoptosis and gene induction.

Main Methods:

  • Utilized a novel, sensitive DNA binding assay on cell lysates.
  • Analyzed p53 protein induction and DNA binding after inducing DNA damage.
  • Assessed downstream gene (p21) induction and apoptosis.
  • Examined NDN2/p53 association in SCC cells.

Main Results:

  • Normal keratinocytes showed sustained p53 binding to consensus DNA and p21 induction.
  • Most endogenous p53 proteins could bind to mismatched DNA, correlating with total p53 levels.
  • SCC cells displayed defects in p53 induction and DNA binding, with increased NDN2/p53 association.
  • p53 binding to mismatched DNA correlated with transcription-independent apoptosis induction.

Conclusions:

  • Activated p53 performs transcription-dependent functions (growth arrest, DNA repair), varying by cell type.
  • Wild-type p53 proteins are generally capable of binding to damaged DNA.
  • Loss of p53 DNA binding impairs apoptosis, potentially causing chemotherapy resistance.
  • p53 DNA binding profiling could enhance treatment response prediction and guide targeted therapies.

Related Experiment Videos